ParTec AG · ISIN: DE000A3E5A34 · Research | Analyses | Ratings

Buy

Original-Research: ParTec AG - from First Berlin Equity Research GmbH 22.11.2024 / 11:20 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions. Classification of First Berlin Equity Research GmbH to ParTec AG Company Name: ParTec AG ISIN: DE000A3E5A34   Rea...

+++ Corporate Insights +++- Company news, directors dealings, net short positions

Current analyst assessments

On this page you will find current analyst assessments of renowned research houses, which make their assessments on the business development of listed companies available for publication and distribution via our content partner EQS-Newswire.
Reset Filter
Source: -
20 November 2024 02:55PM
Good momentum, modest risk
Hardman & Co Investor Forum Research on Custodian Property Income REIT (CREI): Good momentum, modest risk  The structure and investment remit of the real estate investment trust (REIT) have been proven to be resilient and position it strongly for the short- and medium-term future. The investment return emphasis is on income, which is generated...
Hardman & Co Research
Source: -
20 November 2024 11:30AM
Equity raise and third-party capital update
Analyst interview | Financials Q&A on Duke Capital (DUKE) | Equity raise and third-party capital update  Duke Capital (DUKE) is the topic of conversation when Hardman & Co Analyst Mark Thomas joins DirectorsTalk. In this interview, Mark discusses recent developments at Duke Capital, touching on key topics such as their equity raise and p...
Hardman & Co Research
Source: -
19 November 2024 01:45PM
High-growth maritime artificial intelligence play
Hardman & Co Investor Forum Research on Windward (WNWD): High-growth maritime artificial intelligence play  Windward is a fast-growing predictive analytics company that is focused on digitalising the global maritime industry. Windward’s AI-powered decision platform offers a wide-ranging view of the maritime ecosystem and enables stakeholders...
Hardman & Co Research
Source: -
18 November 2024 02:20PM
Taking Duke Capital to the next level
Hardman & Co Research on Duke Capital (DUKE): Taking Duke Capital to the next level   In our April 2024 initiation, we highlighted that DUKE, by optimising the best of equity and debt, aimed to achieve equity-type returns with debt levels of risk. We highlighted four pillars of returns, namely: i) term credit; ii) participating preference sha...
Hardman & Co Research
Source: -
13 November 2024 12:25PM
6 November fireworks
Hardman & Co Research on NB Private Equity Partners CM day: 6 November fireworks  The key takeaways from NBPE’s 6 November CM day, in our view, were i) positive market indications, including exits and an increase in the correlation between operating company EBITDA growth and NAV growth, ii) NB’s platform brings unique benefits: accessing deal...
Hardman & Co Research
Source: -
12 November 2024 01:15PM
Operating companies’ widening margins and strong EBITDA growth
Analyst interview | Investment Companies Q&A on ICG Enterprise Trust (ICGT) | Operating companies’ widening margins and strong EBITDA growth  ICG Enterprise Trust (ICGT) is the topic of conversation when Hardman & Co analyst Mark Thomas joins DirectorsTalk Interviews. Mark Thomas discusses the recent performance and strategic direction o...
Hardman & Co Research
Source: -
12 November 2024 11:33AM
EDX Medical (EDX) Investor Forum
GB00BNDMJS47
Hardman & Co Video Event | EDX Medical (EDX) Investor Forum We are delighted to announce that EDX Medical (EDX) will be presenting at Hardman & Co's upcoming Investor Forum at 3:00pm this Thursday 14 November 2024. Register for the event to secure your place and submit questions. EDX Medical Group plc, listed on the Apex Segment of the A...
Hardman & Co Research
Source: -
11 November 2024 03:00PM
Shield Therapeutics (STX) Investor Forum
Hardman & Co Video Event | Shield Therapeutics (STX) Investor Forum We are delighted to announce that Shield Therapeutics (STX) will be presenting at Hardman & Co's upcoming Investor Forum at 3:00pm this Thursday 14 November 2024. Register for the event to secure your place and submit questions. A commercial-stage pharmaceutical company,...
Hardman & Co Research
Source: -
11 November 2024 02:10PM
Hardman Talks Video | Polar Capital Technology Trust Interview
GB00BR3YV268
Hardman Talks Video | Polar Capital Technology Trust Interview In this Hardman Talks Keith Hiscock, CEO of Hardman & Co, talks to Alastair Unwin, Deputy Manager of Polar Capital Technology Trust. Despite the explosion of coverage and interest in the technology sector at the moment, Polar Capital Technology Trust is one of just three investmen...
Hardman & Co Research
Source: -
05 November 2024 02:50PM
Custodian Property Income REIT (CREI) Investor Forum
Hardman & Co Video Event | Custodian Property Income REIT (CREI) Investor Forum We are delighted to announce that Custodian Property Income REIT (CREI) will be presenting at Hardman & Co's upcoming Investor Forum at 3:00pm on Thursday 14 November 2024. Register for the event to secure your place and submit questions. Custodian is well po...
Hardman & Co Research
Source: -
04 November 2024 02:15PM
Windward (WNWD) Investor Forum
Hardman & Co Video Event | Windward (WNWD) Investor Forum We are delighted to announce that Windward (WNWD) will be presenting at Hardman & Co's upcoming Investor Forum at 3:00pm on Thursday 14 November 2024. Register for the event to secure your place and submit questions. Windward is an exciting UK-listed AI company with an innovative ...
Hardman & Co Research
Source: -
01 November 2024 01:00PM
Understanding the discount, its rise, and future prospects
Hardman & Co analyst interview | Diversified Financial Services Q&A on Real Estate Credit Investments (RECI) | Understanding the discount, its rise, and future prospects Real Estate Credit Investments (RECI) Plc is the topic of conversation when Hardman & Co analyst Mark Thomas joins DirectorsTalk Interviews. In this interview, Mark ...
Hardman & Co Research
Source: -
28 October 2024 12:30PM
The unique value of co-investment in private equity
Hardman & Co analyst interview | Closed End Investments Q&A on NB Private Equity Partners (NBPE) | The unique value of co-investment in private equity NB Private Equity Partners (NBPE) is the topic of conversation when Mark Thomas, analyst at Hardman & Co joins DirectorsTalk Interviews. In this discussion, Mark outlines how NB Privat...
Hardman & Co Research
Source: -
23 October 2024 08:30AM
14% EBITDA growth + widening margins
Hardman & Co Research on ICG Enterprise Trust plc: Portfolio: 14% EBITDA growth + widening margins   The key message from ICGT’s 1HFY’25 results (to July) is the continued strength of the operating companies, which delivered an average 14% LTM EBITDA growth. Margins have widened by ca.5% (average revenue growth 9.4%), which should help alla...
Hardman & Co Research
Source: -
15 October 2024 04:25PM
Why the discount has been closing and its outlook
Hardman & Co Research on Real Estate Credit Investments (RECI): Why the discount has been closing and its outlook   RECI’s discount has halved over the past six months. We believe this is due to both actions taken by the trust (with an active buyback programme, changing asset mix and enhanced disclosure of highest-risk positions) and more f...
Hardman & Co Research
Source: -
15 October 2024 11:05AM
1H24 deal activity rebounding
Hardman & Co analyst interview | Closed-ended investments Q&A on Apax Global Alpha (APAX) | 1H24 deal activity rebounding   Apax Global Alpha (APAX) is the topic of conversation when Mark Thomas, analyst at Hardman & Co joins DirectorsTalk Interviews. In this interview, key insights are provided on Apax Global Alpha’s performance du...
Hardman & Co Research
Source: -
14 October 2024 11:05AM
Estimates suspended
Hardman & Co Research on Surface Transforms (SCE): Estimates suspended   Interim results released on 30 September showed revenue up 58%. The loss before tax widened to £7.6m from £5.6m 1H23. Operationally, the volume ramp-up is continuing but at a rate below target, with yields improving (but also below target), and ongoing downstream process...
Hardman & Co Research
Source: -
11 October 2024 10:50AM
2024 interim results a steady performance
Hardman & Co analyst interview | Life assurance Q&A on Chesnara plc (CSN) | 2024 interim results a steady performance Chesnara plc is the topic of conversation when Hardman & Co analyst, Brian Moretta joins DirectorsTalk. In this interview with Brian, key insights are provided on Chesnara plc following the release of its 2024 interim...
Hardman & Co Research
Source: -
08 October 2024 02:10PM
adding value in attractive co-investment sector
Hardman & Co Research on NB Private Equity Partners (NBPE): NB: adding value in attractive co-investment sector   In our initiation, we highlighted that NBPE is uniquely focused in the co-investment sector of PE. Our report underlined why this sector has especially appealing return, cashflow, asset selection, risk management, and GP access ...
Hardman & Co Research
Source: -
07 October 2024 04:15PM
17 consecutive months of positive returns
Hardman & Co analyst interview | Closed End Investments Q&A on Volta Finance (VTAS) | 17 consecutive months of positive returns Volta Finance plc is the topic of discuss when Hardman & Co analyst Mark Thomas joins DirectorsTalk Interviews. Mark discusses the recent performance of Volta Finance, highlighting the company’s impressive 1...
Hardman & Co Research
Source: -
02 October 2024 08:45AM
Good fund performance and solid results
Hardman & Co Research on City of London Investment Group (CLIG): Good fund performance and solid results   City of London has announced its full-year results for 2024. As stated in the trading statement, FUM was $10.24bn, a 9% increase over the year. While market performance offset net outflows, there was a significant improvement in the la...
Hardman & Co Research
Source: -
01 October 2024 12:30PM
Presentation and Q&A with Management
Hardman Talks Video | Chesnara (CSN) Presentation and Q&A with Management In this episode of Hardman Talks, our Financials analyst Brian Moretta introduces Chesnara‘s CEO Steve Murray and CFO Tom Howard to discuss Chesnara’s recent interim results. Watch it here: https://youtu.be/jGY1iJSR7IQ Steve presents an overview of Chesnara's strong pe...
Hardman & Co Research
Source: -
30 September 2024 11:45AM
Strong bounce back continues
GG00BYYLRY96
Hardman & Co Research on The International Stock Exchange (TISE): Strong bounce back continues   The International Stock Exchange (TISE) had an excellent half year to June 2024: revenue was up 22% to £6.4m and fully diluted EPS +27% to 105p. The second interim dividend was raised 67% to 75p, reflecting the new, higher payout, dividend polic...
Hardman & Co Research
Source: -
26 September 2024 12:36PM
1H’24 deal activity coming back strongly
Hardman & Co Research on Apax Global Alpha (APAX): 1H’24 deal activity coming back strongly   The key messages from AGA’s 1H’24 results were i) a strong rebound in deal activity both for investments and exits (the regular announcements mean this trend was expected), ii) strong growth in investee company EBITDA growth (organic 12.6%, up from...
Hardman & Co Research
Source: -
26 September 2024 09:15AM
Steady as she goes!
Hardman & Co Research on Chesnara Plc (CSN): Steady as she goes!   Chesnara has announced its 1H’24 results. The main features were positive equity market returns, offset to some extent by further adverse lapse experience. Economic Value profit of £20.2m was behind the 1H’23 result of £32.6m (excl. acquisitions). Economic Value saw a small de...
Hardman & Co Research
Source: -
23 September 2024 08:15AM
Maiden pre-tax profit
Hardman & Co Research on Tissue Regenix (TRX): Maiden pre-tax profit   TRX is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL®) and bone (BioRinse®). It has a broad portfolio of products used in biosurgery, orthopaedics and dental markets. Investment in tissue ...
Hardman & Co Research
Source: NuWays AG
23 September 2024 08:15AM
Maiden pre-tax profit
Hardman & Co Research on Tissue Regenix (TRX): Maiden pre-tax profit   TRX is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL®) and bone (BioRinse®). It has a broad portfolio of products used in biosurgery, orthopaedics and dental markets. Investment in tissue ...
Hardman & Co Research
Source: -
11 September 2024 05:25PM
FY’24 - another year of outperformance
Hardman & Co Research | Closed End Investments Volta Finance Limited (VTAS) | FY’24: another year of outperformance   Volta’s monthly to its FY-end of July reported an NAV total return of 19.7% while annualised cash receipts are 22% of the July NAV, consistent with levels seen since mid’22. For 16 consecutive months, it has generated positiv...
Hardman & Co Research
Source: -
11 September 2024 01:25PM
Focusing on successful execution
Hardman & Co Research on Shield Therapeutics (STX): Focusing on successful execution   Shield is a commercial-stage pharma company delivering specialty products that address the unmet medical need of patients with iron deficiency (ID). Since its July 2021 US launch, Shield and Viatris have increased physician awareness of the differentiating...
Hardman & Co Research
Source: -
03 September 2024 01:17PM
Strategic moves and market potential
Hardman & Co analyst interview | Automotive components Q&A on Surface Transforms (SCE) | Strategic moves and market potential Surface Transforms plc (SCE) is the topic of conversation when Hardman & Co analyst Mike Foster speaks to DirectorsTalk Interviews. In this interview, Mike Foster discusses the recent developments at Surface T...
Hardman & Co Research
Source: -
30 August 2024 03:00PM
Hardman & Co Q&A on H&T Group (HAT) | 1H24 results curate's egg of good and bad
Hardman & Co analyst interview | Finance and credit services Q&A on H&T Group (HAT) | 1H24 results curate's egg of good and bad H&T Group (HAT) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk Interviews. In this interview, Mark offers insights into H&T Group's recent 1H'24 financ...
Hardman & Co Research
Source: -
20 August 2024 12:50PM
1H’24 results - Four-one at half time, but the one wins
Hardman & Co Research on H&T Group: 1H’24 results: Four-one at half time, but the one wins   H&T 1H’24 results saw pre-tax profits rise 12.5% from 1H’23 to £9.9m. We have identified five key ongoing business messages, four of them favourable and one unfavourable. The scale of the latter, though, means we have reduced our FY’24 estim...
Hardman & Co Research
Source: -
15 August 2024 03:05PM
Hardman & Co Q&A on H&T Group (HAT) | Putting H&T Group’s pawnbroking business into a global perspective
Analyst interview | Financials Q&A on H&T Group (HAT) | Putting H&T Group’s pawnbroking business into a global perspective   H&T Group Plc (LON:HAT) is the topic of conversation when Hardman & Co analyst Mark Thomas joins DirectorsTalk Interviews.   In this latest interview, Mark Thomas discusses the global pawnbroking indu...
Hardman & Co Research
Source: -
13 August 2024 10:50AM
Pre-close trading, AGM and prospects
Hardman & Co Research on Surface Transforms (SCE): Pre-close trading, AGM and prospects   Surface Transforms (SCE) is delivering its £390m order book but still faces headwinds. It is knocking down the obstacles, giving detailed explanation of progress, and, indeed, output has been consistently good since late June. Clearly, this is not as ea...
Hardman & Co Research
Source: -
08 August 2024 01:30PM
Positive markets add to FUM and maintain dividend
Hardman & Co Research on City of London Investment Group (CLIG): Positive markets add to FUM and maintain dividend   City of London has announced its FUM for 4Q’24 and the full year. It was another positive quarter for the group, with FUM rising 1% from $10.10bn to $10.24bn. Over the financial year, FUM have increased 8.7% and are at their ...
Hardman & Co Research
Source: -
06 August 2024 01:45PM
1H’24 results - multiple options to get the most from the franchise
Hardman & Co analyst interview | Banks Q&A on Arbuthnot Banking Group (ARBB) | 1H’24 results: multiple options to get the most from the franchise Arbuthnot Banking Group plc (ARBB) is the topic of conversation when Hardman & Co analyst Mark Thomas joins DirectorsTalk Interviews. In this latest interview, Mark Thomas offers an in-dept...
Hardman & Co Research
Source: -
05 August 2024 12:57PM
Strategy and resilience
Hardman & Co analyst interview | Investment Companies Q&A on Real Estate Credit Investments (RECI) | Strategy and resilience  Real Estate Credit Investments (RECI) is the topic of conversation when Hardman & Co analyst Mike Foster joins DirectorsTalk Interviews. In this interview, Mike shares his insights on RECI. The discussion cove...
Hardman & Co Research
Source: -
02 August 2024 10:45AM
Hardman & Co Video | Polar Capital (PCFT) Interview
Hardman Talks Video | Polar Capital (PCFT) Interview In this Hardman Talks Keith Hiscock, CEO of Hardman & Co, sits down with Tom Dorner, Co-Manager of the Polar Capital Global Financials Trust. They discuss the current financial landscape, emphasizing the strategies employed by Polar Capital to navigate market challenges and leverage opportu...
Hardman & Co Research
Source: -
30 July 2024 12:40PM
1H’24 - optimising the franchise value
Hardman & Co Research on Arbuthnot Banking Group (ARBB) 1H’24: optimising the franchise value   ABG’s 1H'24 results showed the group’s continued evolution to optimise its franchise value. 2023 saw the peak benefits from ABG’s relationship deposit franchise in the recent rising rate environment. Margins could be widened while still giving cus...
Hardman & Co Research
Source: -
25 July 2024 02:02PM
Capital Markets Day
Hardman & Co Research on Real Estate Credit Investments (RECI): Capital Markets Day   RECI benefits from deep expertise, not only in selecting assets but in having the capability to protect assets where positions need attention. As part of the larger Cheyne debt investor specialist – with over $11bn assets under management – RECI has top-ti...
Hardman & Co Research
Source: -
24 July 2024 12:47PM
Record cashflows in FY’24
Hardman & Co analyst interview | Financials Q&A on Duke Capital (DUKE) | Record cashflows in FY’24 Duke Capital plc (DUKE) is the topic of conversation when Hardman & Co analyst Mark Thomas joins DirectorsTalk Interviews. In this interview, Mark discusses the recent performance and outlook of Duke Capital, which has achieved record c...
Hardman & Co Research
Source: -
23 July 2024 05:52PM
the global perspective for H&T
Hardman & Co Research on H&T Group: Pawnbroking: the global perspective for H&T   In this note, we put pawnbroking into a global and historical context: i) the global market is large, ca.$40bn, UK just ca.5%; ii) pawnbroking is widely adopted across a range of cultures/geographies from China, India, Islamic countries to US, Europe a...
Hardman & Co Research
Source: -
23 July 2024 11:52AM
CM day presentation – How Apax adds value
Hardman & Co analyst interview | Investment Companies Q&A on Apax Global Alpha (APAX) | CM day presentation – How Apax adds value  Apax Global Alpha (APAX) is the topic of conversation when Hardman & Co analyst Mark Thomas joins DirectorsTalk Interviews. In this interview, Mark talks through the key highlights of Apax’s recent develo...
Hardman & Co Research
Source: -
12 July 2024 01:42PM
record cashflows
Hardman & Co Research on Duke Capital (DUKE): FY’24 results: record cashflows   In our April 2024 initiation, we highlighted that DUKE, by optimising the best of equity and debt, aimed to achieve equity-type returns with debt levels of risk. We highlighted four pillars of returns, namely: i) term credit; ii) participating preference share ele...
Hardman & Co Research
Source: -
11 July 2024 11:38AM
Value added by defensive growth strategy
Analyst interview | Investment Companies Q&A on ICG Enterprise Trust (ICGT) | Value added by defensive growth strategy  ICG Enterprise Trust (ICGT) is the topic of conversation when Hardman & Co analyst Mark Thomas joins DirectorsTalk Interviews. Mark delves into the insights and strategies outlined in his recent report CM day 2024: defe...
Hardman & Co Research
Source: -
10 July 2024 11:42AM
further proof of value added by Apax
Hardman & Co Research on Apax Global Alpha (APAX): CM day: further proof of value added by Apax   The key messages from APAX’s well-received 2024 CM day and related announcements were: i) a new capital allocation policy with a set 11p dividend (current yield ca.7%) and creation of a distribution pool for future buybacks (if the discount is ...
Hardman & Co Research
Source: -
01 July 2024 11:38AM
Leading the way in leisure industry solutions
Analyst interview | Technology Q&A on accesso Technology Group (ACSO) | Leading the way in leisure industry solutions Accesso Technology (ACSO) is the topic of conversation when Hardman & Co analyst Richard Jeans joins DirectorsTalk Interviews. Richard Jeans offers a comprehensive overview of accesso Technology Group, a leading provider ...
Hardman & Co Research
Source: -
28 June 2024 01:35PM
CM day 2024 - defensive growth value creation
Hardman & Co Research on ICG Enterprise Trust (ICGT): CM day 2024: defensive growth value creation   The key messages from ICGT’s June 2024 shareholder seminar were i) ICGT has a focused and differentiated investment strategy with a dedicated investment team, ii) operating performance remains strong and capital structures are well positioned...
Hardman & Co Research
Info
The information presented here was provided by our content partner EQS. The assessments of the analyst houses were transmitted in the original via the news service EQS-Newswire for publication via the affiliated distribution networks.
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.